Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

476
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
476
Local Anesthetics: Pharmacokinetics01:13

Local Anesthetics: Pharmacokinetics

712
The potency and duration of action of local anesthetics (LAs) are determined by their pharmacokinetics. Pharmacokinetics describes how LAs are absorbed, distributed, metabolized, and eliminated from the body. When administered to the vascular tissues, LAs are quickly absorbed and enter the systemic circulation, reducing their localized effects. Adding vasoconstrictors such as epinephrine to LAs reduces their absorption into the systemic circulation, making them clinically effective. The...
712
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

445
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
445
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

691
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
691
Depolarizing Blockers: Pharmocokinetics01:19

Depolarizing Blockers: Pharmocokinetics

298
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
298
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

88
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
88

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Ethnopharmacological insights into native medicinal plants for cancer management by indigenous and local communities of Africa: A systematic review.

Journal of ethnopharmacology·2025
Same author

Cost-benefit analysis of rib fixation for multiple rib fractures in US trauma patients.

The journal of trauma and acute care surgery·2025
Same author

Characteristics of Long-Term Survivors With Peritoneal Mesothelioma - Insights From the National Cancer Database.

The American surgeon·2025
Same author

Nature's answer to thyroid cancer: unraveling eclipta prostrata's hidden potential through <i>in silico</i> molecular exploration.

Journal of biomolecular structure & dynamics·2025
Same author

Refractory Gastric Outlet Obstruction Due to a Duodenal Stricture in the Setting of a Cholecystoduodenal Fistula.

Cureus·2025
Same author

Rib Hemangiomas: Intriguing Findings from a Systematic Review of Rare Thoracic Tumors.

Journal of clinical medicine·2024

相关实验视频

Updated: May 20, 2025

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
10:05

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Published on: July 7, 2016

8.2K

"优化"用于心脏收缩度调制装置的麻醉剂.

Samit Ghia1, Ashanay Allen2, Ranjit Suri3

  • 1Department of Anesthesiology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Staten Island, NY, USA.

The Journal of innovations in cardiac rhythm management
|March 24, 2025
PubMed
概括

本案例报告讨论了Optimizer®智能植入式脉冲发生器,这是一个心脏收缩度调制 (CCM) 装置. 麻醉选择和电磁干扰是CCM设备植入和功能的关键考虑因素.

科学领域:

  • 心脏病学 心脏病学
  • 麻醉学 麻醉学
  • 生物医学工程 生物医学工程

背景情况:

  • 心脏收缩度调制 (CCM) 设备,如Optimizer®智能植入式脉冲发生器,旨在改善心力衰竭患者的心脏功能.
  • 这些设备在心脏耐火期内通过穿静脉导线向右心室隔膜传递非刺激性的电信号.
关键词:
心脏麻醉的心脏麻醉调节心脏收缩能力的调节.电力生理学 电力生理学心脏衰竭是因为心脏衰竭.

更多相关视频

Delivery of Cardioactive Therapeutics in a Porcine Myocardial Infarction Model
07:20

Delivery of Cardioactive Therapeutics in a Porcine Myocardial Infarction Model

Published on: February 10, 2023

1.2K
Advanced Cardiac Rhythm Management by Applying Optogenetic Multi-Site Photostimulation in Murine Hearts
08:43

Advanced Cardiac Rhythm Management by Applying Optogenetic Multi-Site Photostimulation in Murine Hearts

Published on: August 26, 2021

2.3K

相关实验视频

Last Updated: May 20, 2025

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
10:05

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Published on: July 7, 2016

8.2K
Delivery of Cardioactive Therapeutics in a Porcine Myocardial Infarction Model
07:20

Delivery of Cardioactive Therapeutics in a Porcine Myocardial Infarction Model

Published on: February 10, 2023

1.2K
Advanced Cardiac Rhythm Management by Applying Optogenetic Multi-Site Photostimulation in Murine Hearts
08:43

Advanced Cardiac Rhythm Management by Applying Optogenetic Multi-Site Photostimulation in Murine Hearts

Published on: August 26, 2021

2.3K